OncoCyte Corporation

NASDAQ:OCX

2.84 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013
Revenue 1.8811.5030.9587.7271.2160000000
Cost of Revenue 1.1411.090.9767.5391.8550.3440.5590.580.3870.28300
Gross Profit 0.740.413-0.0180.188-0.639-0.344-0.559-0.58-0.387-0.28300
Gross Profit Ratio 0.3930.275-0.0190.024-0.5250000000
Reseach & Development Expenses 9.8399.2947.30113.6319.86.7946.5147.1745.6774.5273.9622.943
General & Administrative Expenses 10.20410.74121.88122.33616.78813.2817.0079.2325.4634.1911.0110.552
Selling & Marketing Expenses 3.9442.7951.13211.1676.4942.1641.6812.4431.1980.32400
SG&A 14.14813.53623.01333.50323.28215.4458.68811.6755.4634.1911.0110.552
Other Expenses 36.6532.719-0.067-0.0370.027-0.0030.091000.002-0.0110
Operating Expenses 60.6425.63730.31447.13433.08222.23915.20218.84911.148.7184.9733.495
Operating Income -61.041-25.136-17.997-46.946-29.711-22.239-15.202-18.849-11.14-8.718-4.973-3.495
Operating Income Ratio -32.451-16.724-18.786-6.076-24.4330000000
Total Other Income Expenses Net 0.3780.281-0.6150.854-1.475-0.187-0.552-0.526-0.028-0.017-0.0130
Income Before Tax -60.663-24.855-18.612-73.358-31.186-22.426-15.754-19.375-11.168-8.735-4.986-3.495
Income Before Tax Ratio -32.25-16.537-19.428-9.494-25.6460000000
Income Tax Expense 0054.828-9.261-1.254-0.097-0.3360.217-0.387-0.262-0.0090
Net Income -60.663-27.781-73.44-64.097-29.932-22.329-15.754-19.375-11.168-8.735-4.986-3.495
Net Income Ratio -32.25-18.484-76.66-8.295-24.6150000000
EPS -4.64-3.75-13.26-14.42-9.14-8.71-8.32-12.83-8.42-8.32-15.36-10.77
EPS Diluted -4.64-3.75-13.26-14.42-9.14-8.71-8.32-12.83-8.42-8.32-15.36-10.77
EBITDA -59.015-23.123-13.315-48.457-30.54-21.895-15.202-18.269-11.14-8.435-4.692-3.218
EBITDA Ratio -31.374-15.385-13.899-6.271-25.1150000000